drugset / Trial / NCT04914936
A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The study will evaluate one-way interaction of calcium carbonate, omeprazole, or rifampin on ACP-196.
Timeline
- Start
- 2014-09-21
- Primary completion
- 2014-10-16
- Completion
- 2014-10-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acalabrutinib | Small molecule | 100 mg | Oral |
| Subject | Calcium carbonate | Other / unclassified | 1 g | Oral |
| Subject | Omeprazole | Other / unclassified | 40 mg | Oral |
| Subject | Rifampin | Small molecule | 600 mg | Oral |
Indications
No indication recorded.